Canada markets closed

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3592-0.0108 (-2.93%)
At close: 3:59PM EDT

Khiron Life Sciences Corp.

2300-550 Burrard Street
Vancouver, BC V6C 2B5
Canada
705 527 3564
http://www.khiron.ca

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Alvaro Francisco TorresCo-Founder, CEO & DirectorN/AN/A1979
Ms. Wendy Kaufman C.A., CPA, CPAChief Financial OfficerN/AN/AN/A
Mr. Vicente FoxStrategic Advisor & DirectorN/AN/A1943
Mr. Andres GalofreCo-Founder & VP of Bus. Devel.sN/AN/A1982
Mr. Manuel BuendiaVP of OperationsN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers under the ILANS and Zerenia brands; and develops CBD-based cosmeceutical products under the Kuida brand name. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada.

Corporate Governance

Khiron Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.